247 related articles for article (PubMed ID: 12665499)
1. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure.
Vrtovec B; Delgado R; Zewail A; Thomas CD; Richartz BM; Radovancevic B
Circulation; 2003 Apr; 107(13):1764-9. PubMed ID: 12665499
[TBL] [Abstract][Full Text] [Related]
2. Relation of B-type natriuretic peptide level in heart failure to sudden cardiac death in patients with and without QT interval prolongation.
Vrtovec B; Knezevic I; Poglajen G; Sebestjen M; Okrajsek R; Haddad F
Am J Cardiol; 2013 Mar; 111(6):886-90. PubMed ID: 23273526
[TBL] [Abstract][Full Text] [Related]
3. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
Berger R; Huelsmann M; Strecker K; Moertl D; Moser P; Bojic A; Pacher R
Eur J Clin Invest; 2005 Jan; 35(1):24-31. PubMed ID: 15638816
[TBL] [Abstract][Full Text] [Related]
4. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the QTc interval after cardiac transplantation.
Vrtovec B; Radovancevic R; Thomas CD; Yazdabakhsh AP; Smart FW; Radovancevic B
J Heart Lung Transplant; 2006 Jan; 25(1):29-35. PubMed ID: 16399527
[TBL] [Abstract][Full Text] [Related]
6. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
8. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
9. Pump failure death and sudden cardiac death in patients with cardiac dysfunction: a search for prognostic predictive factors--a long-term follow-up study.
Usuku H; Nakayama M; Sumida H; Yamamuro M; Izumiya Y; Suzuki S; Kusuhara K; Ueno H; Sugiyama S; Yoshimura M; Ogawa H
J Cardiol; 2010 Jan; 55(1):55-64. PubMed ID: 20122549
[TBL] [Abstract][Full Text] [Related]
10. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
Gwechenberger M; Pacher R; Berger R; Zorn G; Moser P; Stanek B; Huelsmann M
J Heart Lung Transplant; 2005 Dec; 24(12):2190-5. PubMed ID: 16364870
[TBL] [Abstract][Full Text] [Related]
11. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
[TBL] [Abstract][Full Text] [Related]
12. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
Taniguchi T; Kawasaki T; Miyai N; Kamitani T; Kawasaki S; Sugihara H
J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide levels in obese patients with advanced heart failure.
Horwich TB; Hamilton MA; Fonarow GC
J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.
Gwechenberger M; Hülsmann M; Berger R; Graf S; Springer C; Stanek B; Pacher R
J Heart Lung Transplant; 2004 Jul; 23(7):839-44. PubMed ID: 15261178
[TBL] [Abstract][Full Text] [Related]
15. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry.
Assmus B; Fischer-Rasokat U; Honold J; Seeger FH; Fichtlscherer S; Tonn T; Seifried E; Schächinger V; Dimmeler S; Zeiher AM;
Circ Res; 2007 Apr; 100(8):1234-41. PubMed ID: 17379833
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome.
Detaint D; Messika-Zeitoun D; Avierinos JF; Scott C; Chen H; Burnett JC; Enriquez-Sarano M
Circulation; 2005 May; 111(18):2391-7. PubMed ID: 15883225
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.
Mehra MR; Uber PA; Potluri S; Ventura HO; Scott RL; Park MH
Am J Cardiol; 2004 Aug; 94(4):454-8. PubMed ID: 15325928
[TBL] [Abstract][Full Text] [Related]
19. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.
Straus SM; Kors JA; De Bruin ML; van der Hooft CS; Hofman A; Heeringa J; Deckers JW; Kingma JH; Sturkenboom MC; Stricker BH; Witteman JC
J Am Coll Cardiol; 2006 Jan; 47(2):362-7. PubMed ID: 16412861
[TBL] [Abstract][Full Text] [Related]
20. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study.
Linnemann B; Janka HU
Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):215-22. PubMed ID: 12845560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
